September 2026 Quarter Production Update

Alkane produced 40,740 AuEq oz and sold 38,348 AuEq oz in Q1 FY27, including 37,950 oz of gold and 172 tonnes of antimony. It reported $459 million in cash, bullion and listed investments, including $440 million of cash and bullion, and was debt-free apart from $16 million of equipment finance. The company reiterated FY27 group guidance of 163,000–177,000 AuEq oz and A$2,900–A$3,200/oz AISC, while investing in growth projects and paying a maiden $27 million dividend.

Analysis

The quarter looks broadly consistent with, but does not yet de-risk, FY27 guidance: production is near the quarterly pace implied by the annual range, leaving little evidence of a meaningful early-year cushion. The key question is execution as reinvestment ramps, not the headline cash balance. Planned growth and exploration spending is substantial; liquidity gives Alkane room to fund it, but project delays or cost overruns could consume flexibility before the expected mine-life and production benefits arrive. The reported A$6,035/oz gold reference price is not a realized-price or margin measure, so do not translate the gap to AISC guidance directly into earnings without checking realized prices, costs and currency exposure.

Costerfield’s antimony contribution also makes AuEq a less clean operating yardstick: commodity-price changes can move equivalent ounces without a corresponding change in gold output. Antimony production materially exceeded sales this quarter; this may reflect shipment timing or inventory accumulation, and should be reconciled in the October activities report rather than assumed to be a demand problem. Remaining hedge deliveries limit some gold-price upside over the next three quarters, while the large reinvestment program creates a 6–18 month execution test. The contrarian point: strong liquidity is a buffer, not proof that growth capital will earn attractive returns. With no valuation or market-reaction data supplied, this release alone does not support a directional equity call.

Key Decisions for Investors

• No immediate directional position on this release alone; avoid treating the cash balance or production print as a standalone buy signal.
• Use the 23 October activities report as the near-term catalyst check: verify mine-by-mine production trajectory against FY27 guidance, realized prices and AISC, growth-capital spend, and the explanation for antimony sales lagging production.
• Reassess only if the report shows sustained production below the pace required by guidance, rising unit costs, or project spending materially ahead of plan; those would weaken the liquidity-and-growth thesis.
• Treat any improvement in AuEq with caution unless gold ounces and antimony sales/inventory conversion also support it; rising antimony prices alone can flatter the equivalent-ounce metric.